Comparative assessment of 18F-PSMA-1007 biodistribution at 60 and 120 minutes after administration by PET/CT in prostate cancer patients
Open Access
- 14 April 2023
- journal article
- research article
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 14 (1) , 63-72
Abstract
Сравнительная оценка биораспределения 18F-ПСМА-1007 через 60 и 120 минут после внутривенного введения при ПЭТ/КТ у пациентов, обследованных по поводу рака предстательной железыKeywords
This publication has 6 references indexed in Scilit:
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesCA: A Cancer Journal for Clinicians, 2021
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesCA: A Cancer Journal for Clinicians, 2018
- 18F-PSMA-1007 PET/CT at 60 and 120 minutes in patients with prostate cancer: biodistribution, tumour detection and activity kineticsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2018
- Diagnostic Efficacy of 68 Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate CancerJournal of Urology, 2016
- Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical ProstatectomyJournal of Nuclear Medicine, 2015
- Comparison of Gallium-68 and Fluorine-18 imaging characteristics in positron emission tomographyApplied Radiation and Isotopes, 2013